Related Experiment Video
Updated: May 28, 2026
07:46
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Use of antibiotics in bronchiectasis
1Department of Respiratory/Sleep Medicine, Monash Medical Centre, Clayton, 246 Clayton Rd, Clayton, Melbourne 3168, Australia. paul.king@monash.edu.au
Reviews on Recent Clinical Trials
|October 26, 2011
Summary
Antibiotics are key for treating bronchiectasis, a chronic airway disease. While new therapies like inhaled antibiotics and macrolides show promise for long-term use, evidence remains preliminary, and antibiotic resistance is a concern.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Bronchiectasis involves abnormal bronchial widening, often resulting from chronic airway infections.
- It represents a significant and prevalent cause of respiratory illness.
- Antibiotic therapy is the primary treatment modality for this condition.
Purpose of the Study:
- To review the current use of antibiotics in managing bronchiectasis.
- To discuss short-term (exacerbations) and long-term (maintenance) antibiotic strategies.
- To highlight emerging antibiotic classes and resistance concerns.
Main Methods:
- Literature review of antibiotic use in bronchiectasis.
- Analysis of short-term versus long-term antibiotic administration.
- Examination of novel therapeutic approaches, including inhalational antibiotics and macrolides.
Main Results:
- Antibiotics are administered for both acute exacerbations and as maintenance therapy.
- Inhalational antibiotics and macrolides are emerging options for long-term management.
- Current trial data is limited by small subject numbers, suggesting preliminary findings.
Conclusions:
- Antibiotic therapy is central to bronchiectasis management.
- Newer antibiotic strategies offer potential for long-term control.
- Further research is needed due to preliminary data and the risk of antibiotic resistance.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...